{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:23:14Z","timestamp":1772241794696,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1208\/s12248-013-9451-0","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T22:08:59Z","timestamp":1358978939000},"page":"455-464","source":"Crossref","is-referenced-by-count":107,"title":["A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam"],"prefix":"10.1208","volume":"15","author":[{"given":"A. R.","family":"Maharaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. N.","family":"Edginton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"issue":"5","key":"9451_CR1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/clpt.2012.19","volume":"91","author":"R Leong","year":"2012","unstructured":"Leong R, Vieira ML, Zhao P, Mulugeta Y, Lee CS, Huang SM, et al. Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials. Clin Pharmacol Ther. 2012;91(5):926\u201331.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"9451_CR2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2004.02225.x","volume":"59","author":"S Bjorkman","year":"2005","unstructured":"Bjorkman S. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs. Br J Clin Pharmacol. 2005;59(6):691\u2013704.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"9451_CR3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2165\/00003088-200645100-00005","volume":"45","author":"AN Edginton","year":"2006","unstructured":"Edginton AN, Schmitt W, Willmann S. Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin Pharmacokinet. 2006;45(10):1013\u201334.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"9451_CR4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1460-9592.2010.03323.x","volume":"21","author":"TN Johnson","year":"2011","unstructured":"Johnson TN, Rostami-Hodjegan A. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice. Paediatr Anaesth. 2011;21(3):291\u2013301.","journal-title":"Paediatr Anaesth"},{"issue":"4","key":"9451_CR5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1289\/ehp.0800073","volume":"117","author":"AN Edginton","year":"2009","unstructured":"Edginton AN, Ritter L. Predicting plasma concentrations of bisphenol A in children younger than 2\u00a0years of age after typical feeding schedules, using a physiologically based toxicokinetic model. Environ Health Perspect. 2009;117(4):645\u201352.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"9451_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/clpt.2012.64","volume":"92","author":"JS Barrett","year":"2012","unstructured":"Barrett JS, Della Casa AO, Laer S, Meibohm B. Physiologically based pharmacokinetic (PBPK) modeling in children. Clin Pharmacol Ther. 2012;92(1):40\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"9451_CR7","unstructured":"Lexi-Comp Online (2012) Pediatric & neonatal Lexi-drugs online. Hudson, Ohio, Lexi-Comp, Inc. 18-6-2012. Ref Type: Online Source."},{"issue":"3","key":"9451_CR8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jpeds.2007.07.050","volume":"152","author":"P Kumar","year":"2008","unstructured":"Kumar P, Walker JK, Hurt KM, Bennett KM, Grosshans N, Fotis MA. Medication use in the neonatal intensive care unit: current patterns and off-label use of parenteral medications. J Pediatr. 2008;152(3):412\u20135.","journal-title":"J Pediatr"},{"issue":"6","key":"9451_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.PCC.0000144710.13710.2E","volume":"5","author":"MD Twite","year":"2004","unstructured":"Twite MD, Rashid A, Zuk J, Friesen RH. Sedation, analgesia, and neuromuscular blockade in the pediatric intensive care unit: survey of fellowship training programs. Pediatr Crit Care Med. 2004;5(6):521\u201332.","journal-title":"Pediatr Crit Care Med"},{"key":"9451_CR10","unstructured":"Federal Register (2003) List of drugs for which pediatric studies are needed. Federal Register 2003 Jan 9;68(13):2789\u201390."},{"issue":"6","key":"9451_CR11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1365-2125.2011.04036.x","volume":"72","author":"PK Chin","year":"2011","unstructured":"Chin PK, Jensen BP, Larsen HS, Begg EJ. Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects. Br J Clin Pharmacol. 2011;72(6):985\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"9451_CR12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.2042-7158.1982.tb04201.x","volume":"34","author":"M Divoll","year":"1982","unstructured":"Divoll M, Greenblatt DJ. Effect of age and sex on lorazepam protein binding. J Pharm Pharmacol. 1982;34(2):122\u20133.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"9451_CR13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/clpt.1991.117","volume":"50","author":"WR Crom","year":"1991","unstructured":"Crom WR, Relling MV, Christensen ML, Rivera GK, Evans WE. Age-related differences in hepatic drug clearance in children: studies with lorazepam and antipyrine. Clin Pharmacol Ther. 1991;50(2):132\u201340.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"9451_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cpt1976203329","volume":"20","author":"DJ Greenblatt","year":"1976","unstructured":"Greenblatt DJ, Schillings RT, Kyriakopoulos AA, Shader RI, Sisenwine SF, Knowles JA, et al. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam. Clin Pharmacol Ther. 1976;20(3):329\u201341.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"9451_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jps.2600680119","volume":"68","author":"DJ Greenblatt","year":"1979","unstructured":"Greenblatt DJ, Shader RI, Franke K, MacLaughlin DS, Harmatz JS, Allen MD, et al. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci. 1979;68(1):57\u201363.","journal-title":"J Pharm Sci"},{"issue":"6","key":"9451_CR16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1365-2125.1976.tb00354.x","volume":"3","author":"R Verbeeck","year":"1976","unstructured":"Verbeeck R, Tjandramaga TB, Verberckmoes R, De Schepper PJ. Biotransformation and excretion of lorazepam in patients with chronic renal failure. Br J Clin Pharmacol. 1976;3(6):1033\u20139.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"9451_CR17","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","volume":"95","author":"T Rodgers","year":"2006","unstructured":"Rodgers T, Rowland M. Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci. 2006;95(6):1238\u201357.","journal-title":"J Pharm Sci"},{"issue":"6","key":"9451_CR18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jps.20322","volume":"94","author":"T Rodgers","year":"2005","unstructured":"Rodgers T, Leahy D, Rowland M. Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci. 2005;94(6):1259\u201376.","journal-title":"J Pharm Sci"},{"issue":"6","key":"9451_CR19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/jps.20323","volume":"94","author":"T Rodgers","year":"2005","unstructured":"Rodgers T, Leahy D, Rowland M. Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat. J Pharm Sci. 2005;94(6):1237\u201348.","journal-title":"J Pharm Sci"},{"issue":"8\u20139","key":"9451_CR20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/j.1552-4604.1977.tb05641.x","volume":"17","author":"DJ Greenblatt","year":"1977","unstructured":"Greenblatt DJ, Comer WH, Elliott HW, Shader RI, Knowles JA, Ruelius HW. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results. J Clin Pharmacol. 1977;17(8\u20139):490\u20134.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"9451_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jps.2600710227","volume":"71","author":"DJ Greenblatt","year":"1982","unstructured":"Greenblatt DJ, Divoll M, Harmatz JS, Shader RI. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam. J Pharm Sci. 1982;71(2):248\u201352.","journal-title":"J Pharm Sci"},{"issue":"11","key":"9451_CR22","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1177\/00912700122012779","volume":"41","author":"DP Wermeling","year":"2001","unstructured":"Wermeling DP, Miller JL, Archer SM, Manaligod JM, Rudy AC. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol. 2001;41(11):1225\u201331.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"9451_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-007-9053-5","volume":"34","author":"S Willmann","year":"2007","unstructured":"Willmann S, Hohn K, Edginton A, Sevestre M, Solodenko J, Weiss W, et al. Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs. J Pharmacokinet Pharmacodyn. 2007;34(3):401\u201331.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"7","key":"9451_CR24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2165\/00003088-200645070-00004","volume":"45","author":"AN Edginton","year":"2006","unstructured":"Edginton AN, Schmitt W, Voith B, Willmann S. A mechanistic approach for the scaling of clearance in children. Clin Pharmacokinet. 2006;45(7):683\u2013704.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"9451_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2125.1991.tb05607.x","volume":"32","author":"SM Sim","year":"1991","unstructured":"Sim SM, Back DJ, Breckenridge AM. The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes. Br J Clin Pharmacol. 1991;32(1):17\u201321.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"9451_CR26","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1208\/ps040104","volume":"4","author":"PJ McNamara","year":"2002","unstructured":"McNamara PJ, Alcorn J. Protein binding predictions in infants. AAPS PharmSci. 2002;4(1):E4.","journal-title":"AAPS PharmSci"},{"issue":"13","key":"9451_CR27","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2165\/00003088-200241130-00005","volume":"41","author":"J Alcorn","year":"2002","unstructured":"Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin Pharmacokinet. 2002;41(13):1077\u201394.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"9451_CR28","first-page":"1379","volume":"64","author":"JJ Irwin","year":"2001","unstructured":"Irwin JJ, Kirchner JT. Anemia in children. Am Fam Physician. 2001;64(8):1379\u201387.","journal-title":"Am Fam Physician"},{"issue":"1","key":"9451_CR29","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1208\/ps020103","volume":"2","author":"WL Hayton","year":"2000","unstructured":"Hayton WL. Maturation and growth of renal function: dosing renally cleared drugs in children. AAPS PharmSci. 2000;2(1):E3.","journal-title":"AAPS PharmSci"},{"key":"9451_CR30","doi-asserted-by":"crossref","unstructured":"Chamberlain JM, Capparelli EV, Brown KM, Vance CW, Lillis K, Mahajan P, et al. Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus. J Pediatr 2011;160:667-672; Nov 1.","DOI":"10.1016\/j.jpeds.2011.09.048"},{"key":"9451_CR31","unstructured":"Zhao P. Regulatory experience in physiologically-based pharmacokinetic (PBPK) models in pediatric submissions. FDA\u2014Advisory Committee for Pharmaceutical Science and Clinical Pharmacology. 14-3-2012. Conference Presentation."},{"issue":"3","key":"9451_CR32","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1460-9592.2010.03473.x","volume":"21","author":"AN Edginton","year":"2011","unstructured":"Edginton AN. Knowledge-driven approaches for the guidance of first-in-children dosing. Paediatr Anaesth. 2011;21(3):206\u201313.","journal-title":"Paediatr Anaesth"},{"issue":"5","key":"9451_CR33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/BF01062393","volume":"7","author":"WL Chiou","year":"1979","unstructured":"Chiou WL. Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination. J Pharmacokinet Biopharm. 1979;7(5):527\u201336.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"3","key":"9451_CR34","first-page":"159","volume":"63","author":"A Pyka","year":"2006","unstructured":"Pyka A, Babuska M, Zachariasz M. A comparison of theoretical methods of calculation of partition coefficients for selected drugs. Acta Pol Pharm. 2006;63(3):159\u201367.","journal-title":"Acta Pol Pharm"},{"issue":"4","key":"9451_CR35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0731-7085(02)00686-6","volume":"31","author":"GV Popovic","year":"2003","unstructured":"Popovic GV, Sladic DM, Stefanovic VM, Pfendt LB. Study on protolytic equilibria of lorazepam and oxazepam by UV and NMR spectroscopy. J Pharm Biomed Anal. 2003;31(4):693\u20139.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"9451_CR36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01065172","volume":"10","author":"H Boxenbaum","year":"1982","unstructured":"Boxenbaum H. Comparative pharmacokinetics of benzodiazepines in dog and man. J Pharmacokinet Biopharm. 1982;10(4):411\u201326.","journal-title":"J Pharmacokinet Biopharm"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-013-9451-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-013-9451-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-013-9451-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T20:35:52Z","timestamp":1562618152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-013-9451-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["9451"],"URL":"https:\/\/doi.org\/10.1208\/s12248-013-9451-0","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}